Simulating drug-eluting stents: progress made and the way forward

Sean McGinty, Christopher McCormick, Sean McKee, Marcus Wheel, Simon Kennedy, Keith G. Oldroyd

Research output: Contribution to conferencePaper

103 Downloads (Pure)


Drug-eluting stents have significantly improved the treatment of coronary artery disease. Compared with their bare metal predecessors, they offer reduced rates of restenosis and thus represent the current gold standard in percutaneous coronary interventions. Drug-eluting stents have been around for over a decade, and while progress is continually being made, they are not suitable in all patients and lesion types. Furthermore there are still real concerns over incomplete healing and late stent thrombosis. In this paper, some modelling approaches are reviewed and the future of modelling and simulation in this field is discussed.
Original languageEnglish
Number of pages8
Publication statusPublished - Jul 2013
EventSpecial Session on Modelling and Simulation in Biology and Medicine (BIOMED 2013) - Reykajvik, Iceland
Duration: 29 Jul 201331 Jul 2013


ConferenceSpecial Session on Modelling and Simulation in Biology and Medicine (BIOMED 2013)


  • drug-eluting stents
  • coronary artery disease
  • progress
  • bare metal
  • gold standard

Cite this